Success Metrics

Active Trials
0(0%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Other(1)

Detailed Status

unknown1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A

Trials by Status

unknown1100%

Recent Activity

0 active trials
Showing 1 of 1
unknown

Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL

NCT04300803

Clinical Trials (1)

Showing 1 of 1 trials
NCT04300803

Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL

Unknown

All 1 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
1